BioCardia, Inc. Diluted Shares Outstanding (Weighted Average)
BioCardia, Inc. (BCDA) reported Diluted Shares Outstanding (Weighted Average) of 10.81 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-12
- BioCardia, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 10.81M shares, a 133.24% increase year-over-year.
- BioCardia, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 5.06M shares.
- BioCardia, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 4.64M shares.
- BioCardia, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2016-09-30 was 230.54M shares, a 0.11% increase year-over-year.
- BioCardia, Inc. weighted average number of shares outstanding, diluted for fiscal 2015 was 230.29M shares, a 0.00% change from fiscal 2014.
- BioCardia, Inc. weighted average number of shares outstanding, diluted for fiscal 2014 was 230.29M shares, a 0.00% change from fiscal 2013.
- BioCardia, Inc. weighted average number of shares outstanding, diluted for fiscal 2013 was 230.29M shares, a 0.00% change from fiscal 2012.
- BioCardia, Inc. weighted average number of shares outstanding, diluted for fiscal 2012 was 230.29M shares, a 0.00% change from fiscal 2011.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-03-31 | 10.81M shares 10-Q · filed 2026-05-15 | |||
| 2025-06-30 | 5.06M shares 10-Q · filed 2026-08-12 | 4.85M shares 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | 4.64M shares 10-Q · filed 2026-05-15 | |||
| 2016-09-30 | 230.54M shares 10-Q · filed 2016-10-17 | 230.42M shares derived: average of 2 quarters · filed 2016-10-17 | 230.38M shares 10-Q · filed 2016-10-17 | 230.35M shares derived: average of 4 quarters · filed 2016-10-17 |
| 2016-06-30 | 230.29M shares 10-Q · filed 2016-08-02 | 230.29M shares 10-Q · filed 2016-08-02 | 230.29M shares derived: average of 3 quarters · filed 2016-08-02 | 230.29M shares derived: average of 4 quarters · filed 2016-10-17 |
| 2016-03-31 | 230.29M shares 10-Q · filed 2016-05-03 | 230.29M shares derived: average of 2 quarters · filed 2016-05-03 | 230.29M shares derived: average of 3 quarters · filed 2016-10-17 | 230.29M shares derived: average of 4 quarters · filed 2016-10-17 |
| 2015-12-31 | 230.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | 230.29M shares derived: average of 2 quarters · filed 2016-10-17 | 230.29M shares derived: average of 3 quarters · filed 2016-10-17 | 230.29M shares 10-K · filed 2016-03-25 |
| 2015-09-30 | 230.29M shares 10-Q · filed 2016-10-17 | 230.29M shares derived: average of 2 quarters · filed 2016-10-17 | 230.29M shares 10-Q · filed 2016-10-17 | 230.29M shares derived: average of 4 quarters · filed 2016-10-17 |
| 2015-06-30 | 230.29M shares 10-Q · filed 2016-08-02 | 230.29M shares 10-Q · filed 2016-08-02 | 230.29M shares derived: average of 3 quarters · filed 2016-08-02 | 230.29M shares derived: average of 4 quarters · filed 2016-08-02 |
| 2015-03-31 | 230.29M shares 10-Q · filed 2016-05-03 | 230.29M shares derived: average of 2 quarters · filed 2016-05-03 | 230.29M shares derived: average of 3 quarters · filed 2016-05-03 | 230.29M shares derived: average of 4 quarters · filed 2016-05-03 |
| 2014-12-31 | 230.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | 230.29M shares derived: average of 2 quarters · filed 2016-03-25 | 230.29M shares derived: average of 3 quarters · filed 2016-03-25 | 230.29M shares 10-K · filed 2016-03-25 |
| 2014-09-30 | 230.29M shares 10-Q · filed 2015-10-29 | 230.29M shares derived: average of 2 quarters · filed 2015-10-29 | 230.29M shares 10-Q · filed 2015-10-29 | 230.29M shares derived: average of 4 quarters · filed 2015-10-29 |
| 2014-06-30 | 230.29M shares 10-Q · filed 2015-08-12 | 230.29M shares 10-Q · filed 2015-08-12 | 230.29M shares derived: average of 3 quarters · filed 2015-08-12 | 230.29M shares derived: average of 4 quarters · filed 2015-08-12 |
| 2014-03-31 | 230.29M shares 10-Q · filed 2015-05-12 | 230.29M shares derived: average of 2 quarters · filed 2015-05-12 | 230.29M shares derived: average of 3 quarters · filed 2015-05-12 | 230.29M shares derived: average of 4 quarters · filed 2015-05-12 |
| 2013-12-31 | 230.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24 | 230.29M shares derived: average of 2 quarters · filed 2015-03-24 | 230.29M shares derived: average of 3 quarters · filed 2015-03-24 | 230.29M shares 10-K · filed 2015-03-24 |
| 2013-09-30 | 230.29M shares 10-Q · filed 2014-11-06 | 230.29M shares derived: average of 2 quarters · filed 2014-11-06 | 230.29M shares 10-Q · filed 2014-11-06 | 230.29M shares derived: average of 4 quarters · filed 2014-11-06 |
| 2013-06-30 | 230.29M shares 10-Q · filed 2014-08-06 | 230.29M shares 10-Q · filed 2014-08-06 | 230.29M shares derived: average of 3 quarters · filed 2014-08-06 | 230.29M shares derived: average of 4 quarters · filed 2014-08-06 |
| 2013-03-31 | 230.29M shares 10-Q · filed 2014-05-12 | 230.29M shares derived: average of 2 quarters · filed 2014-05-12 | 230.29M shares derived: average of 3 quarters · filed 2014-05-12 | 230.29M shares derived: average of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | 230.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-24 | 230.29M shares derived: average of 2 quarters · filed 2014-03-24 | 230.29M shares derived: average of 3 quarters · filed 2014-03-24 | 230.29M shares 10-K · filed 2014-03-24 |
| 2012-09-30 | 230.29M shares 10-Q · filed 2013-11-01 | 230.29M shares derived: average of 2 quarters · filed 2013-11-01 | 230.29M shares 10-Q · filed 2013-11-01 | 230.29M shares derived: average of 4 quarters · filed 2013-11-01 |
| 2012-06-30 | 230.29M shares 10-Q · filed 2013-07-26 | 230.29M shares 10-Q · filed 2013-07-26 | 230.29M shares derived: average of 3 quarters · filed 2013-07-26 | 230.29M shares derived: average of 4 quarters · filed 2013-07-26 |
| 2012-03-31 | 230.29M shares 10-Q · filed 2013-05-10 | 230.29M shares derived: average of 2 quarters · filed 2013-05-10 | 230.29M shares derived: average of 3 quarters · filed 2013-05-10 | 230.29M shares derived: average of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | 230.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | 230.29M shares derived: average of 2 quarters · filed 2013-03-22 | 230.29M shares derived: average of 3 quarters · filed 2013-03-22 | 230.29M shares 10-K · filed 2013-03-22 |
| 2011-09-30 | 230.29M shares 10-Q · filed 2012-11-08 | 230.29M shares derived: average of 2 quarters · filed 2012-11-08 | 230.29M shares 10-Q · filed 2012-11-08 | 230.29M shares derived: average of 4 quarters · filed 2012-11-08 |
| 2011-06-30 | 230.29M shares 10-Q · filed 2012-08-10 | 230.29M shares 10-Q · filed 2012-08-10 | 230.29M shares derived: average of 3 quarters · filed 2012-08-10 | 230.29M shares derived: average of 4 quarters · filed 2012-08-10 |
| 2011-03-31 | 230.29M shares 10-Q · filed 2012-05-15 | 230.29M shares derived: average of 2 quarters · filed 2012-05-15 | 230.29M shares derived: average of 3 quarters · filed 2012-05-15 | 230.29M shares derived: average of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | 230.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | 230.29M shares derived: average of 2 quarters · filed 2012-03-29 | 230.29M shares derived: average of 3 quarters · filed 2012-03-29 | 230.29M shares 10-K · filed 2012-03-29 |
| 2010-09-30 | 230.29M shares 10-Q · filed 2011-11-15 | 230.29M shares derived: average of 2 quarters · filed 2011-11-17 | 230.29M shares 10-Q · filed 2011-11-15 | |
| 2010-06-30 | 230.29M shares 10-Q/A · filed 2011-11-17 | 230.29M shares 10-Q/A · filed 2011-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |